Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES Gains 4%; BSE HEALTHCARE Index Up 0.4%
Fri, 6 Sep 9:40

GLENMARK LIFE SCIENCES Gains 4%; BSE HEALTHCARE Index Up 0.4%Image source: Nikada/www.istockphoto.com

GLENMARK LIFE SCIENCES share price has zoomed 4% and is presently trading at Rs 1,135.0.

Meanwhile, the BSE HEALTHCARE index is at 43,751.1 (up 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 3.2%) and SUVEN PHARMACEUTICALS (up 3.0%).

KIMS (down 1.3%) and CAPLIN POINT (down 1.0%) are among the top losers today.

Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 624.9 to Rs 1,135.0, registering a gain of Rs 510.1 (up 81.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,804.5 to 43,751.1, registering a gain of 57.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 133.5%), GRANULES INDIA (up 131.5%) and Glenmark Pharma (up 126.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,200.9 .

The top losers among the BSE Sensex today are SBI (down 1.3%) and Ultratech Cement (down 0.5%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 25,145.4 . SBI and Coal India are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,628.1 to 82,200.9, registering a gain of 16,572.8 points (up 25.3%).

GLENMARK LIFE SCIENCES Financial Update...

GLENMARK LIFE SCIENCES net profit fell 17.7% YoY to Rs 1,115 million for the quarter ended June 2024, compared to a profit of Rs 1,355 million a year ago. Net sales rose 1.8% to Rs 5,886 million during the period as against Rs 5,785 million in April-June 2023.

For the year ended March 2024, GLENMARK LIFE SCIENCES reported 0.8% increase in net profit to Rs 4,709 million compared to net profit of Rs 4,670 million during FY23. Revenue of the company grew 5.6% to Rs 22,832 million during FY24.

The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 31.1.


Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Gains 4%; BSE HEALTHCARE Index Up 0.4%". Click here!